StockData
AnaptysBio, Inc logo

AnaptysBio, Inc (ANAB) stock

ANABNasdaqPharmaceutical PreparationsFiscal year ends June 30
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 12, 2026Score 9/30
$49.24+2.63 (+5.64%)

Close on Oct 19, 2026Market cap $2.28BP/E –Yield –

AnaptysBio enterprise value

Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.

AnaptysBio's enterprise value was $1.30B on Oct 19, 2026, against $460.76M a year earlier. Over the last 5 years it ranged from -$162.53M to $1.67B, with a median of $92.29M.

Enterprise Value at the end of each year

PeriodPeriod endValueChange
2026Oct 19, 2026$1.30B+102.4%
2025Dec 31, 2025$642.27M–
2024Dec 31, 2024-$161.53M–
2023Dec 29, 2023-$33.55M-123.5%
2022Dec 30, 2022$142.83M-45.5%
2021Dec 31, 2021$261.89M+389.0%
2020Dec 31, 2020$53.56M–
2019Dec 31, 2019-$127.50M-119.8%
2018Dec 31, 2018$643.66M-48.9%
2017Dec 29, 2017$1.26B–

More AnaptysBio figures

See a number that looks wrong?